AR094866A1 - CRYSTAL FORMS OF AN INHIBITOR OF PROLIL HYDROXYLASE - Google Patents

CRYSTAL FORMS OF AN INHIBITOR OF PROLIL HYDROXYLASE

Info

Publication number
AR094866A1
AR094866A1 ARP140100570A ARP140100570A AR094866A1 AR 094866 A1 AR094866 A1 AR 094866A1 AR P140100570 A ARP140100570 A AR P140100570A AR P140100570 A ARP140100570 A AR P140100570A AR 094866 A1 AR094866 A1 AR 094866A1
Authority
AR
Argentina
Prior art keywords
prolil
hydroxylase
inhibitor
crystal forms
isoquinoline
Prior art date
Application number
ARP140100570A
Other languages
Spanish (es)
Inventor
D Thompson Michael
Witschi Claudia
M Park Jung
J Martinelli Michael
A Yeowell David
P Arend Michael
Original Assignee
Fibrogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fibrogen Inc filed Critical Fibrogen Inc
Publication of AR094866A1 publication Critical patent/AR094866A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente divulgación se relaciona con las formas sólidas cristalinas del ácido [(4-hidroxi-1-metil-7-fenoxi-isoquinolina-3-carbonil)-amino]-acético, con el proceso de preparación de las formas, así como con las composiciones farmacéuticas y los métodos de uso de las mismas. compuestos útiles para tratar casos de anemia, isquemia e hipoxia. Reivindicación 1: Ácido [(4-hidroxi-1-metil-7-fenoxi-isoquinolina-3-carbonil)-amino]-acético cristalino (Compuesto A - Forma A) caracterizado por un difractograma de rayos X de polvo que comprende los siguientes picos: 8,5, 16,2, y 27,4 º2q ± 0,2 º2q.The present disclosure relates to the crystalline solid forms of [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl) -amino] -acetic acid, with the process of preparing the forms, as well as with pharmaceutical compositions and methods of use thereof. compounds useful for treating cases of anemia, ischemia and hypoxia. Claim 1: Crystalline [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl) -amino] -acetic acid (Compound A - Form A) characterized by a powder X-ray diffractogram comprising the following peaks: 8.5, 16.2, and 27.4 º2q ± 0.2 º2q.

ARP140100570A 2013-02-22 2014-02-24 CRYSTAL FORMS OF AN INHIBITOR OF PROLIL HYDROXYLASE AR094866A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361768297P 2013-02-22 2013-02-22

Publications (1)

Publication Number Publication Date
AR094866A1 true AR094866A1 (en) 2015-09-02

Family

ID=56119049

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100570A AR094866A1 (en) 2013-02-22 2014-02-24 CRYSTAL FORMS OF AN INHIBITOR OF PROLIL HYDROXYLASE

Country Status (1)

Country Link
AR (1) AR094866A1 (en)

Similar Documents

Publication Publication Date Title
DOP2018000257A (en) PIRIDINES REPLACED WITH HETEROARILO AND METHODS OF USE
CR20160119A (en) NEW COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHYSICAL FIBROSIS
NZ716840A (en) Combination formulation of two antiviral compounds
CR20200276A (en) SULFAMOYLARYLAMIDES AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B (DIVISIONAL EXP. 2015-0059)
AR096046A1 (en) DERIVATIVES OF 2,2-DIFLUOROPROPANAMIDE OF METHYL BARDOXOLONE, POLYMODIC FORMS AND METHODS OF USE
UY35590A (en) NEW COMPOUNDS FOR CANCER TREATMENT
NI201500142A (en) 3-ACETYLAMINO-1 (PHENYL-HETEROARIL-AMINOCARBONIL OR PHENYL-HETEROARYL-CARBONYLAMINE) DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
GT201300207A (en) HETEROARILO DERIVATIVES AS MODULATORS OF NACHR ALFA 7
NI201500096A (en) CHEMICAL COMPOUNDS
CU20120137A7 (en) HYDROCHLORIDE HYDROCHLORIDE HYDROCHLORIDE AND PREPARATION OF THIS
UY35704A (en) COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF THE MEK
CR20160016A (en) SUBSTITUTED PIRAZOLPIRIDINS
GT201500247A (en) IMIDAZOPIRIDAZINAS REPLACED
CR20150245A (en) NEW PROCESS FOR THE PREPARATION OF COMPOUNDS FOR USE IN CANCER TREATMENT
CU20160015A7 (en) COMPOUNDS THAT HAVE A RING CONTAINING SALICYLIC NITROGEN UNITED TO A USEFUL BICYCLE HETEROARIL GROUP AS INHIBITORS RORC2
MX364400B (en) Tetracycline compounds.
MY185971A (en) Pyranodipyridine compound
CR20120655A (en) CRYSTAL FORM DELTA OF THE ARGININE SALT OF PERINDOPRILE, ITS PREPARATION PROCEDURE, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
AR089929A1 (en) PROCESS TO MANUFACTURE A NAFTIRIDINE DERIVATIVE
AR080203A1 (en) SOLID FORMS THAT INCLUDE A CYCLOPROPILAMIDE
CU20120136A7 (en) HYDROBROMIDE HYDROBROMIDE HYDROBROMIDE AND PREPARATION OF THIS
AR094866A1 (en) CRYSTAL FORMS OF AN INHIBITOR OF PROLIL HYDROXYLASE
AR102569A1 (en) SYNTHESIS OF PI3K INHIBITOR, CRYSTAL AND SALES FORMS OF THE SAME AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS
BR112015030589A8 (en) polymorphic forms of icotinib phosphate, pharmaceutical composition comprising said forms and uses thereof

Legal Events

Date Code Title Description
FC Refusal